In an article published in the April issue of The Journal of Nuclear Medicine, researchers at Stanford University in California provide a template for assessing new positron emission tomography (PET) radiotracers that can accurately identify molecules in cancer cells that prevent the immune system from attacking the cancer. {read more here}

A PET imaging probe developed by Massachusetts General Hospital (MGH) investigators appears able to diagnose and stage pulmonary fibrosis—an often life-shortening lung disease—as well as monitor the response to treatment. {read more here}

PET imaging can identify the underlying cell mutations that cause non-small cell lung cancer, according to a new study published in The Journal of Nuclear Medicine. That information can help physicians select the optimal treatment plan for each patient.  {read more here}

A new study by Dr Ilin Joo and colleagues in South Korea compared the diagnostic performance of FDG PET/MRI to that of FDG PET/CT plus CECT in the preoperative assessment of 37 patients with pancreatic cancer.  {read more here}